Abstract
Endoscopists must be familiar with the macroscopic and histologic type of neoplasias, the potential for malignant conversion, and the kinetics of local and metastatic spread. Investigation into the morphogenesis of early cancer has revealed at least five different morphologic pathways of carcinogenesis in the colon, three different pathways in the stomach, and at least two in the esophagus. These pathways exhibit distinct macroscopic precursor and early malignant lesions. Endoscopic resection R0 en-bloc is curative in mucosal T1a and incipient T1b submucosal differentiated carcinomas of the gastric, esophageal or colonic wall. Apart from histologic grading and lymphatic or venous vascular invasion, vertical submucosal extension of early cancer predicts the probability of established lymph node metastases. To define the vertical and lateral margins of tumor infiltration after en-bloc resection, the specimen must be documented endoscopically and macroscopically and sent oriented to the pathology laboratory to obtain a precise pathological statement for decision on further management and follow-up.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fujimori T, et al. Pathological diagnosis of early colorectal carcinoma and its clinical implications. Digestion. 2009;79(Suppl 1):40–51.
Gotoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.
Takubo K, et al. Early squamous cell carcinoma of the oesophagus: the Japanese viewpoint. Histopathology. 2007;51:733–42.
Kudo S, et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc. 2008;68:S3–47.
Sano Y, et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig Endosc. 2016;28:526–33.
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58:S3–43.
Paris workshop on columnar metaplasia in the esophagus and the esophagogastric junction, Paris, France, December 11–12, 2004. Endoscopy. 2005;37:879–920.
Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113–30.
Lauren P. The Two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
Schlemper RJ, et al. Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer. 1998;82:60–9.
Schlemper RJ, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet. 1997;349:1725–9.
Schlemper RJ, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–5.
Kudo SE. Early colorectal cancer. In:Detection of depressed types of colorectal carcinoma. Tokyo: IGAKU-SHOIN Ltd; 1996.
Muto M, et al. Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G). Dig Endosc. 2016;28:379–93.
Oyama T, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14:105–12.
Ueno H, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127:385–94.
Dunbar KB, et al. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2012;107:850–62. quiz 863
Hirasawa T, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.
Holscher AH, et al. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg. 2011;254:802–7; discussion 807–808.
Kitajima K, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39:534–43.
Stein HJ, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242:566–73; discussion 573–565.
Tajima Y, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–93.
Lugli A, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30:1299–311.
Watanabe T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1–34.
Toyonaga T, et al. Principles of quality controlled endoscopic submucosal dissection with appropriate dissection level and high quality resected specimen. Clin Endosc. 2012;45:362–74.
Vogelstein B, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.
East JE, et al. Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance. Gut. 2015;64:991–1000.
Guinney J, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350–6.
Becht E, et al. Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy. Clin Cancer Res. 2016;22:4057–66.
Hermanek P. Polypectomy in the colorectum histological and oncological aspects. Endoscopy. 1983;15(Suppl 1):158–61.
Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med. 2009;361:1179–87.
Uraoka T, et al. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut. 2006;55:1592–7.
Goto H. Proportion of de novo cancers among colorectal cancers in Japan. Gastroenterology. 2006;131:40–6.
Shimoda T, et al. Early colorectal carcinoma with special reference to its development de novo. Cancer. 1989;64:1138–46.
Ijspeert JEG, et al. Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview. Gut. 2017;66:1225–32.
Makinen MJ. Colorectal serrated adenocarcinoma. Histopathology. 2007;50:131–50.
Oka S, et al. Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest Endosc. 2004;59:213–9.
Leggett B, et al. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138:2088–100.
De Jong AE, et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology. 2004;126:42–8.
East JE, et al. Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut. 2008;57:65–70.
Huneburg R, et al. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy. 2009;41:316–22.
Lecomte T, et al. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol. 2005;3:897–902.
Lynch HT, et al. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–32.
Rijcken FE, et al. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut. 2002;50:382–6.
Watanabe T, et al. Flat adenoma as a precursor of colorectal carcinoma in hereditary nonpolyposis colorectal carcinoma. Cancer. 1996;77:627–34.
Laine L, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489–501. e426.
Magro F, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and Ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–70.
Chiu K, et al. DALM, rest in peace: a pathologist’s perspective on dysplasia in inflammatory bowel disease in the post-DALM era. Mod Pathol. 2018;31:1080–90.
Lim CH, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut. 2003;52:1127–32.
Soetikno R, et al. Paradigm shift in the surveillance and management of dysplasia in inflammatory bowel disease (West). Dig Endosc. 2016;28:266–73.
Thomas T, et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657–68.
Blair V, et al. Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol. 2006;4:262–75.
Cislo M, et al. Distinct molecular subtypes of gastric cancer: from Lauren to molecular pathology. Oncotarget. 2018;9:19427–42.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.
Sobin LH, et al. TNM classification of malignant tumours. Oxford: Wiley-Blackwell; 2009.
Namikawa T, et al. Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma. World J Gastroenterol. 2010;16:4634–9.
Yamazaki K, et al. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol. 2006;12:3803–9.
Tajima Y, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res. 2006;12:6469–79.
Hirota WK, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570–80.
Vieth M, et al. Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch. 2003;442:317–21.
Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570–8.
Yao K, et al. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41:462–7.
Engel LS, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–13.
Quante M, et al. Insights into the pathophysiology of esophageal adenocarcinoma. Gastroenterology. 2018;154:406–20.
Buttar NS, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630–9.
Leers JM, et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg. 2011;253:271–8.
Landau MS, et al. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol. 2014;27:1578–89.
Zemler B, et al. Early Barrett’s carcinoma: the depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion. Virchows Arch. 2010;456:609–14.
Yokoyama A, et al. Risk appraisal and endoscopic screening for esophageal squamous cell carcinoma in Japanese populations. Esophagus. 2007;4:135–43.
Nagata K, Shimizu M. Pathological evaluation of gastrointestinal endoscopic submucosal dissection materials based on Japanese guidelines. World J Gastrointest Endosc. 2012;4:489–99.
Acknowledgments
The authors gratefully acknowledge Susanna Mueller, M.D., Department of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany; and Manfred Stolte, M.D., Institut für Pathologie, Kulmbach, for proofreading of the chapter and focusing on the formal differences in histopathologic criteria of cancer diagnosis used by Japanese and Western pathologists.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing
About this chapter
Cite this chapter
Neureiter, D., Kiesslich, T. (2019). Histopathology of Early Mucosal Neoplasias: Morphologic Carcinogenesis in the GI Tract. In: Berr, F., Oyama, T., Ponchon, T., Yahagi, N. (eds) Atlas of Early Neoplasias of the Gastrointestinal Tract. Springer, Cham. https://doi.org/10.1007/978-3-030-01114-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-01114-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01113-0
Online ISBN: 978-3-030-01114-7
eBook Packages: MedicineMedicine (R0)